High-dose Erythropoietin for Asphyxia and Encephalopathy

NCT02811263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Encephalopathy
Birth Asphyxia

Interventions

DRUG: Normal saline placebo
DRUG: Erythropoietin

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]